Literature DB >> 15039236

Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.

Christoph Schmitz1, Bart P F Rutten, Andrea Pielen, Stephanie Schäfer, Oliver Wirths, Günter Tremp, Christian Czech, Veronique Blanchard, Gerd Multhaup, Payam Rezaie, Hubert Korr, Harry W M Steinbusch, Laurent Pradier, Thomas A Bayer.   

Abstract

According to the "amyloid hypothesis of Alzheimer's disease," beta-amyloid is the primary driving force in Alzheimer's disease pathogenesis. Despite the development of many transgenic mouse lines developing abundant beta-amyloid-containing plaques in the brain, the actual link between amyloid plaques and neuron loss has not been clearly established, as reports on neuron loss in these models have remained controversial. We investigated transgenic mice expressing human mutant amyloid precursor protein APP751 (KM670/671NL and V717I) and human mutant presenilin-1 (PS-1 M146L). Stereologic and image analyses revealed substantial age-related neuron loss in the hippocampal pyramidal cell layer of APP/PS-1 double-transgenic mice. The loss of neurons was observed at sites of Abeta aggregation and surrounding astrocytes but, most importantly, was also clearly observed in areas of the parenchyma distant from plaques. These findings point to the potential involvement of more than one mechanism in hippocampal neuron loss in this APP/PS-1 double-transgenic mouse model of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039236      PMCID: PMC1615337          DOI: 10.1016/S0002-9440(10)63235-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

2.  Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach.

Authors:  C Schmitz; P R Hof
Journal:  J Chem Neuroanat       Date:  2000-10       Impact factor: 3.052

Review 3.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 4.  Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins.

Authors:  L Meda; P Baron; G Scarlato
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

5.  Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

Authors:  D Praticò; K Uryu; S Leight; J Q Trojanoswki; V M Lee
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

6.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

Authors:  O Wirths; G Multhaup; C Czech; V Blanchard; S Moussaoui; G Tremp; L Pradier; K Beyreuther; T A Bayer
Journal:  Neurosci Lett       Date:  2001-06-22       Impact factor: 3.046

7.  Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion.

Authors:  T Borchardt; J Camakaris; R Cappai; C L Masters; K Beyreuther; G Multhaup
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

Review 8.  Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport.

Authors:  T A Bayer; O Wirths; K Majtényi; T Hartmann; G Multhaup; K Beyreuther; C Czech
Journal:  Brain Pathol       Date:  2001-01       Impact factor: 6.508

9.  Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.

Authors:  A Takeuchi; M C Irizarry; K Duff; T C Saido; K Hsiao Ashe; M Hasegawa; D M Mann; B T Hyman; T Iwatsubo
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 10.  Single and multiple transgenic mice as models for Alzheimer's disease.

Authors:  F van Leuven
Journal:  Prog Neurobiol       Date:  2000-06       Impact factor: 11.685

View more
  80 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

2.  Building a more perfect beast: APP transgenic mice with neuronal loss.

Authors:  Dennis W Dickson
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

3.  Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.

Authors:  Caty Casas; Nicolas Sergeant; Jean-Michel Itier; Véronique Blanchard; Oliver Wirths; Nicolien van der Kolk; Valérie Vingtdeux; Evita van de Steeg; Gwenaëlle Ret; Thierry Canton; Hervé Drobecq; Allan Clark; Bruno Bonici; André Delacourte; Jesús Benavides; Christoph Schmitz; Günter Tremp; Thomas A Bayer; Patrick Benoit; Laurent Pradier
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 4.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 5.  Alzheimer's in 3D culture: challenges and perspectives.

Authors:  Carla D'Avanzo; Jenna Aronson; Young Hye Kim; Se Hoon Choi; Rudolph E Tanzi; Doo Yeon Kim
Journal:  Bioessays       Date:  2015-08-07       Impact factor: 4.345

6.  Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.

Authors:  Chenyou Sun; Xiaoming Ou; Jerry M Farley; Craig Stockmeier; Steven Bigler; Roberta Diaz Brinton; Jun Ming Wang
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

Review 7.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

8.  BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice.

Authors:  Masuo Ohno; Sarah L Cole; Marina Yasvoina; Jie Zhao; Martin Citron; Robert Berry; John F Disterhoft; Robert Vassar
Journal:  Neurobiol Dis       Date:  2006-12-20       Impact factor: 5.996

Review 9.  Transdermal delivery of treatment for Alzheimer's disease: development, clinical performance and future prospects.

Authors:  Agnes L F Chan; Yie W Chien; Shun Jin Lin
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques.

Authors:  Anna Pensalfini; Ricardo Albay; Suhail Rasool; Jessica W Wu; Asa Hatami; Hiromi Arai; Lawrence Margol; Saskia Milton; Wayne W Poon; Maria M Corrada; Claudia H Kawas; Charles G Glabe
Journal:  Neurobiol Dis       Date:  2014-08-01       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.